# OnCo record outpace-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/outpace-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "outpace-bio" ;
  schema:name "Outpace Bio"@en ;
  schema:description "Outpace Bio uses computer-aided protein design to build engineered T-cell therapies for solid tumours. It is testing two such therapies in women with ovarian and endometrial cancer that has come back."@en ;
  schema:url <https://onco.cc/companies/outpace-bio/>, <https://outpacebio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://outpacebio.com/>, <https://clinicaltrials.gov/study/NCT07030907>, <https://clinicaltrials.gov/study/NCT07664735>, <https://outpacebio.com/news> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/tcr-t/>, <https://onco.cc/technologies/armored-car/> ;
  onco:targets <https://onco.cc/targets/mesothelin/>, <https://onco.cc/targets/prame/> .